Cleared Special

K202885 - GlucoSure HT Plus Blood Glucose Monitoring System

K202885 is an FDA 510(k) clearance for GlucoSure HT Plus Blood Glucose Monitor..., manufactured by Apex BioTechnology Corp.. The device is a Class 2 Chemistry device with product code NBW cleared through the Special 510(k) pathway after a 352-day FDA review.

K202885 · Apex BioTechnology Corp. · Chemistry device
Download Printable Device Report (PDF) Official FDA 510(k) Summary (PDF)
Optimized for regulatory review, auditing and printing
Sep 2021
Decision
352d
Days
Class 2
Risk

K202885 is an FDA 510(k) clearance for the GlucoSure HT Plus Blood Glucose Monitoring System. Classified as System, Test, Blood Glucose, Over The Counter (product code NBW), Class II - Special Controls.

Submitted by Apex BioTechnology Corp. (Hsinchu, CN). The FDA issued a Cleared decision on September 15, 2021 after a review of 352 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1345 - the FDA in vitro diagnostics and chemistry framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Elevated predicate reliance profile. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

FDA 510(k) Submission Details - K202885

510(k) Number K202885 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 28, 2020
Decision Date September 15, 2021
Days to Decision 352 days
Submission Type Special
Review Panel Chemistry (CH)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
263d slower than avg
Panel avg: 89d · This submission: 352d
Pathway characteristics
Modification to existing cleared device.

NBW Device Classification - Class 2, Special Controls

Product Code NBW System, Test, Blood Glucose, Over The Counter
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.1345
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Chemistry devices follow this clearance model.

Regulatory Peers - NBW System, Test, Blood Glucose, Over The Counter

All 513
Devices cleared under the same product code (NBW) and FDA review panel - the closest regulatory comparables to K202885.
Contour® next GEN Blood Glucose Monitoring System
K193407 · Ascensia Diabetes Care · Dec 2021
MultiSure GK Link Blood Glucose and Ketone Monitoring System
K201880 · Apex BioTechnology Corp. · Oct 2021
CareSens N Feliz Blood Glucose Monitoring System, CareSens N Feliz BT Blood Glucose Monitoring System
K201394 · I-Sens, Inc. · Oct 2021
EASYMAX Tag Self-Monitoring Blood Glucose System
K201258 · Eps Bio Technology Corp. · Sep 2021
CONTOUR® NEXT ONE Blood Glucose Monitoring System
K210687 · Ascensia Diabetes Care · Aug 2021
Finetest Lite Blood Glucose Monitoring System
K203562 · Osang Healthcare Co. , Ltd. · Jul 2021
K202885 · GlucoSure HT Plus Blood Glucose Monitoring System
Download PDF FDA Summary Apex BioTechnology Co…